Monitoring RAS Phenotypic Changes Based on ctDNA to Predict the Efficacy of Cetuximab in Metastatic Colorectal Cancer

ABSTRACT: Interventions: Gold Standard:Clinical outcome;Index test:RAS phenotypic changes in ctDNA Primary outcome(s): RAS gene phenotype;SEN, SPE, ACC, AUC of ROC Study Design: Sequential

DISEASE(S): Colorectal Cancer

PROVIDER: 2687923 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR